Baxter International

CVS Health appoints Michael F. Mahoney to its Board of Directors

Retrieved on: 
Thursday, September 21, 2023
Health informatics, University, Medical device, Diagnosis, Wake Forest University, BSX, Health, Endoscopy, The Advisory Board Company, Baxter International, Patient, Electrophysiology, Boston College, Johnson & Johnson, CVS Health, Boy, NYSE, Urology, Independent, Worldwide, Management, Nursing, Pharmaceutical industry, Boston Scientific

WOONSOCKET, R.I., Sept. 21, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the "Board") of CVS Health, effective November 1.

Key Points: 
  • WOONSOCKET, R.I., Sept. 21, 2023 /PRNewswire/ -- CVS Health Corporation (NYSE: CVS) has appointed Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, to serve on the Board of Directors (the "Board") of CVS Health, effective November 1.
  • "Mike's focus throughout his career – to drive improvements in health outcomes and increase access to care – align with our mission at CVS Health," said CVS Health President and CEO Karen S. Lynch.
  • Mahoney became the CEO of Boston Scientific Corporation in 2012 and became Chairman of the company's Board of Directors in 2016.
  • "We're extremely pleased to have Mike join the Board," said Roger N. Farah, Independent Chair of the Board of CVS Health.

American Kidney Fund, Home Dialyzors United Partner to Host Second Annual Dialysis at Home Summit

Retrieved on: 
Tuesday, September 12, 2023
Infection, American Kidney Fund, Employment, Kidney failure, Travel, Friends, AKF, Peritoneal dialysis, Dialysis, Health equity, Quality of life, AstraZeneca, Baxter International, Kidney disease, Home, Patient, Risk, Kidney, Knowledge, Health, CKD, Caregiver, Health insurance, Medical device

ROCKVILLE, Md., Sept. 12, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has partnered with Home Dialyzors United, a nonprofit advocating on behalf of the home dialyzor community, to host the second annual Dialysis at Home summit on Sept. 14.

Key Points: 
  • ROCKVILLE, Md., Sept. 12, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has partnered with Home Dialyzors United, a nonprofit advocating on behalf of the home dialyzor community, to host the second annual Dialysis at Home summit on Sept. 14.
  • “AKF is proud to partner with Home Dialyzors United for the second time to host this important event.
  • “Home Dialyzors United is thrilled to join forces once again with the American Kidney Fund for our second annual Dialysis at Home virtual event,” said Nieltje Gedney, Executive Director of Home Dialyzors United.
  • Home dialysis options include peritoneal dialysis, conventional home hemodialysis, nocturnal home hemodialysis and short daily home hemodialysis.

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Baxter International Inc. (BAX) Investors of a Class Action Lawsuit and Upcoming Deadline

Retrieved on: 
Monday, September 11, 2023
CASE, LLP, Face, Telephone, COST, Baxter International, Levi, CLASS, NEXT, Court, NYSE, Cryptocurrency, Baxter

NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Baxter International Inc. ("Baxter" or the "Company") (NYSE: BAX) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Baxter investors who were adversely affected by alleged securities fraud between May 25, 2022 and February 8, 2023.
  • Follow the link below to get more information and be contacted by a member of our team:
    BAX investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Baxter International Inc. - BAX

Retrieved on: 
Saturday, September 9, 2023
Baxter, Baxter International, LLP, Pomerantz, News, NYSE, Cryptocurrency

NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX).

Key Points: 
  • NEW YORK, Sept. 09, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Baxter and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

BAX DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors with Losses to Secure Counsel Before Important September 11 Deadline in Securities Class Action – BAX

Retrieved on: 
Saturday, September 9, 2023
Titan, Face, Class, Baxter, Baxter International, Advertising, Court, NYSE, I-Space (Chinese company), Insurance, Tobacco

WHAT TO DO NEXT: To join the Baxter class action, go to https://rosenlegal.com/submit-form/?case_id=17664 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Baxter class action, go to https://rosenlegal.com/submit-form/?case_id=17664 or call Phillip Kim, Esq.
  • If you wish to serve as lead plaintiff, you must move the Court no later than September 11, 2023.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Baxter International Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 11, 2023 – (NYSE: BAX)

Retrieved on: 
Friday, September 8, 2023
Baxter International, NEXT, Fraud, Face, BAX, Holding company, Security (finance)

Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.

Key Points: 
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.
  • DEADLINE: September 11, 2023 Shareholders should not delay in registering for this class action.
  • The deadline to seek to be a lead plaintiff is September 11, 2023.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing

Retrieved on: 
Thursday, September 7, 2023
Standby Equity Distribution Agreement, Indian stock exchange, CDN, Baxter, Risk assessment, Sale, Sepsis, Baxter International, Patient, PMX, Distribution, Finance Secretary (India), TSX, ICU, EAA, NYSE, Security (finance), Note

TORONTO, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the “Company”) is pleased to announce that it has closed its previously announced ”bought deal” private placement of 9.0% convertible unsecured senior notes due November 1, 2026 (the “Notes") of the Company at a price of US$1,000 per Note (the “Issue Price”) for aggregate gross proceeds of US$4,553,000 (the "Offering"). The Offering was conducted by Paradigm Capital Inc. (the “Underwriter”) and consisted of the sale of 4,553 Notes at a price of US$1,000 per Note.

Key Points: 
  • The Offering was conducted by Paradigm Capital Inc. (the “Underwriter”) and consisted of the sale of 4,553 Notes at a price of US$1,000 per Note.
  • The Notes have a face value of US$1,000 per Note, bear interest of 9% and are due on November 1, 2026 (the “Maturity Date”).
  • Each Note is convertible into approximately 15,475,647 Common Shares, subject to customary anti-dilution and make whole fundamental change adjustments.
  • Chris Seto, Chief Executive Officer of Spectral Medical, stated, “We remain encouraged by the continued momentum and pace of patient enrollment in the Tigris study.

Geron Announces Appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer and Treasurer, and the Retirement of Olivia Bloom, Geron's Long-Time Chief Financial Officer

Retrieved on: 
Monday, September 11, 2023
Oncology, Health, Other Science, Research, Science, Pharmaceutical, Biotechnology, Baxalta, CRISPR, Employment, Momenta, Telomerase, Finance, History, Editas Medicine, Baxter International, Genzyme, Imetelstat, Bentley University, Retirement, Corporation, Acquisition, Geron Corporation, Risk, Syndrome, CFO, Johnson & Johnson, Commercial, Treasurer, Genome, Management, Sanofi, Accounting

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer (CFO) and Treasurer, effective September 25, 2023.

Key Points: 
  • Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer (CFO) and Treasurer, effective September 25, 2023.
  • Ms. Robertson's appointment follows the retirement of Olivia Bloom, Geron's incumbent CFO, also effective September 25, 2023.
  • Olivia’s strategic vision, financial prowess and inspiring dedication have been foundational in making Geron what we are today,” said John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer.
  • “In the same breath, I am also thrilled to welcome Michelle Robertson to the Geron executive management team at this important moment in our history.

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Baxter International Inc. (BAX)

Retrieved on: 
Friday, September 8, 2023
Professional Services, Class Action Lawsuit, Baxter, Baxter International, Court, Defendant, Suite, Law, News, NYSE, Face, Cryptocurrency

The Law Offices of Frank R. Cruz reminds investors of the upcoming September 11, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX ) securities between May 25, 2022 and February 8, 2023, inclusive (the “Class Period”).

Key Points: 
  • The Law Offices of Frank R. Cruz reminds investors of the upcoming September 11, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX ) securities between May 25, 2022 and February 8, 2023, inclusive (the “Class Period”).
  • If you purchased or otherwise acquired Baxter securities during the Class Period, you may move the Court no later than September 11, 2023 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

BAXTER DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Baxter International, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 9, 2023
Class Action Lawsuit, Professional Services, Legal, Baxter International, Telephone, Baxter, P.C, Court, Jeanne Eagels, Face, District court, NYSE, News, Person, Security (finance), Cryptocurrency

Investors have until September 11, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until September 11, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Click here to participate in the action.
  • Following this news, Baxter shares fell $5.23 per share, or 11.5%, from $45.37 to close at $40.14 per share on February 9, 2023.
  • Over the course of the Class Period, Baxter’s stock price declined by nearly 50%, eliminating billions of dollars in market capitalization.